Vimarsana
Biggest News Aggregation in the World

Bernd Seizinger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bernd Seizinger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bernd Seizinger Today - Breaking & Trending Today

BioInvent International : Resolutions at BioInvent's Annual General Meeting 2024 - Vimarsana News

BioInvent International : Resolutions at BioInvent's Annual General Meeting 2024

English Swedish ...

Resolutions at BioInvent's Annual General Meeting 2024 - Vimarsana News

Resolutions at BioInvent's Annual General Meeting 2024

LUND, SWEDEN / ACCESSWIRE / May 3, 2024 / BioInvent International (STO:BINV)The Annual General Meeting ("AGM") of BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV) resolved to elect Laura Lassouw-Polman as new Board member, to re-elect the Board members Natalie Berner, Kristoffer B...

Oncolytics Biotech : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 15, 2024 MANAGEMENT INFORMATION CIRCULAR - Form 6-K - Vimarsana News

Oncolytics Biotech : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 15, 2024 MANAGEMENT INFORMATION CIRCULAR - Form 6-K

NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 15, 2024 - AND - MANAGEMENT INFORMATION CIRCULAR ...

This Aptose Biosciences Insider Increased Their Holding In The Last Year - Vimarsana News

This Aptose Biosciences Insider Increased Their Holding In The Last Year

Insiders were net buyers of Aptose Biosciences Inc.'s ( TSE:APS ) stock during the past year. That is, insiders bought...

Source: yahoo.com
Turbine Upsizes its Series A Round to €25.5 Million and Appoints Seasoned Independent Directors to its Board - Vimarsana News

Turbine Upsizes its Series A Round to €25.5 Million and Appoints Seasoned Independent Directors to its Board

-- Enhanced financial resources and expertise will further Turbine's interpretable simulation research and maximize the potential of its Simulated Cell™ platform -- Turbine's proprietary approach pairs